Lv4
740 积分 2024-12-10 加入
Group Sequential and Confirmatory Adaptive Designs in Clinical Trials
1个月前
已完结
Group Sequential and Adaptive Methods for Clinical Trials
1个月前
已完结
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis
2个月前
已完结
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial
5个月前
已完结
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
5个月前
已完结
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
5个月前
已完结
Impact of Real-World Response to First-Line Immunotherapy and Chemotherapy on Subsequent Treatment Outcomes in Patients With Advanced or Metastatic Non–Small Cell Lung Cancer
5个月前
已关闭
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
7个月前
已完结
Exact matching as an alternative to propensity score matching
10个月前
已完结
A Comparison of Two Methods for Adaptive Multi-Arm Two-Stage Design
10个月前
已完结
皖公网安备34019202002308
